Does MYCOPHENOLATE Cause Hyperparathyroidism secondary? 29 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Hyperparathyroidism secondary have been filed in association with MYCOPHENOLATE (mycophenolic acid). This represents 0.4% of all adverse event reports for MYCOPHENOLATE.
29
Reports of Hyperparathyroidism secondary with MYCOPHENOLATE
0.4%
of all MYCOPHENOLATE reports
0
Deaths
28
Hospitalizations
How Dangerous Is Hyperparathyroidism secondary From MYCOPHENOLATE?
Of the 29 reports, 28 (96.6%) required hospitalization.
Is Hyperparathyroidism secondary Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MYCOPHENOLATE. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does MYCOPHENOLATE Cause?
Diarrhoea (622)
Death (615)
Off label use (572)
Drug ineffective (380)
Pyrexia (374)
Blood creatinine increased (305)
Malaise (288)
Hypertension (280)
Haemoglobin decreased (272)
Product use in unapproved indication (272)
What Other Drugs Cause Hyperparathyroidism secondary?
ESOMEPRAZOLE (1,357)
OMEPRAZOLE (1,274)
PANTOPRAZOLE (947)
LANSOPRAZOLE (888)
DEXLANSOPRAZOLE (382)
RABEPRAZOLE (108)
DENOSUMAB (60)
FUROSEMIDE (49)
OMEPRAZOLE\SODIUM BICARBONATE (48)
ESOMEPRAZOLE\NAPROXEN (47)
Which MYCOPHENOLATE Alternatives Have Lower Hyperparathyroidism secondary Risk?
MYCOPHENOLATE vs MYCOPHENOLATE MOFETIL
MYCOPHENOLATE vs MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL
MYCOPHENOLATE vs MYCOPHENOLIC ACID
MYCOPHENOLATE vs MYFORTIC
MYCOPHENOLATE vs MYRBETRIQ